Lipoprotein (a), C-reactive protein and some metabolic cardiovascular risk factors in type 2 DM.
about
Lipoprotein (a) and atherogenic indices in Sudanese patients with type 2 diabetes.Does atorvastatin work more effectively than biguanides in reducing cardiovascular risk factors?Acute phase reactant dynamics and incidence of microvascular dysfunctions in type 2 diabetes mellitus.Variations of lipoprotein(a) levels in the metabolic syndrome: a report from the Maracaibo City Metabolic Syndrome Prevalence StudySerum Lipoprotein (a) Levels in Black South African Type 2 Diabetes Mellitus PatientsInvestigating the Atherogenic Risk of Lipoprotein(a) in Type 2 Diabetic Patients
P2860
Lipoprotein (a), C-reactive protein and some metabolic cardiovascular risk factors in type 2 DM.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Lipoprotein (a), C-reactive pr ...... lar risk factors in type 2 DM.
@ast
Lipoprotein (a), C-reactive pr ...... lar risk factors in type 2 DM.
@en
Lipoprotein (a), C-reactive pr ...... lar risk factors in type 2 DM.
@nl
type
label
Lipoprotein (a), C-reactive pr ...... lar risk factors in type 2 DM.
@ast
Lipoprotein (a), C-reactive pr ...... lar risk factors in type 2 DM.
@en
Lipoprotein (a), C-reactive pr ...... lar risk factors in type 2 DM.
@nl
prefLabel
Lipoprotein (a), C-reactive pr ...... lar risk factors in type 2 DM.
@ast
Lipoprotein (a), C-reactive pr ...... lar risk factors in type 2 DM.
@en
Lipoprotein (a), C-reactive pr ...... lar risk factors in type 2 DM.
@nl
P2860
P356
P1476
Lipoprotein (a), C-reactive pr ...... ular risk factors in type 2 DM
@en
P2093
Alfred O Azenabor
P2860
P2888
P356
10.1186/1758-5996-2-51
P577
2010-07-27T00:00:00Z
P5875
P6179
1004042914